Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Glycyrrhetinic Acid for Potassium and Insulin Resistance in Dialysis
NCT00384384Phase 2Completed
- Sponsor
- Insel Gruppe
- Start
- Aug 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of glycyrrhetinic acid in hyperkalemia, insulin resistance (IR), sponsored by Insel Gruppe. Started Aug 2006; status: completed.
02
Drugs
glycyrrhetinic acid
03
Conditions
hyperkalemiainsulin resistance (IR)
Beyond the preview
Go deeper on NCT00384384.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00384384.